Navigation Links
Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan
Date:7/14/2014

LAVAL, Quebec, July 14, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has filed a premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U.S. Federal Trade Commission (FTC) relating to the proposed acquisition of Allergan, Inc. (NYSE: AGN).

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Forward-looking Statements

This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Canadian securities laws.  These forward-looking statements include, but are not limited to, statements regarding Valeant's offer to acquire Allergan, its financing of the proposed transaction, its expected future performance (including expected results of operations and financial guidance), and the combined company's future financial condition, operating results, strategy and plans.  Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," "opportunity," "tentative," "positioning," "designed," "create," "predict," "project," "seek," "ongoing," "upside," "increases" or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
2. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
3. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
4. Valeant Pharmaceuticals To Present At Industry Conferences
5. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
6. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
7. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
8. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
9. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
10. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
11. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Ill., April 19, 2011 Sysmex, a global ... systems technology, announced today an amended distributorship agreement ... automatically renews for up to four successive one-year ... including the Sysmex pocH-100 i™ , Sysmex KX-21N™, ...
... Premier Research Group Limited announces the re-branding of ... Research Company. With the continued growth in clinical development ... the medical device industry, Premier Research recognises this sector ... D-TARGET was founded in 1997 and acquired ...
Cached Medicine Technology:Sysmex America Signs Distributorship Agreement With LABSCO 2Premier Research Re-brands its Medical Device Business Unit to D-TARGET 2
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting ... auto insurance policy . , Some types of vehicles cannot ... the newly released blog post to see if their vehicle qualifies ... vehicles are some of the cars that cannot be covered by ...
(Date:1/22/2015)... 22, 2015 Step into a macabre ... Science Museum of Virginia. Wicked Plants, the Museum’s latest ... unearths 75 poisonous, carnivorous and diabolical plants inside of ... to uncover the biochemical, physical and neurological processes between ...
(Date:12/26/2014)... The US represents the largest market for CRC across the ... that sales of branded therapies were $2.23 billion. The US ... of the disease, high drug treatment rate, and higher drug ... of CRC therapies over the forecast period will be driven ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... researchers have identified the first biomarker of graft-versus-host disease ... blood test that should solve a treatment dilemma facing ... marrow transplants. The biomarker also makes it possible to ... graft-versus-host disease, or GVHD. GVHD is a serious, ...
... continue climbing to exhaustion may be the only determinant of ... the University of Granada, the objective of which is to ... of sport, shows this to be the case. ... fat percentage and grip strength. Furthermore, existing research was based ...
... CT, ultrasound imaging and MRI, doctors have long been able ... patient,s body, and now a Texas A&M University mathematician is ... , The professor, Peter Kuchment, a leading researcher in mathematical ... process for detecting cancer and many other diseases. , When ...
... Researchers ... working to reduce the radiation exposure associated with CT imaging. A study featured on the ... cancer from CT imaging. , ... Loma Linda, CA (Vocus) January 7, 2010 -- Researchers from the department of radiology and ...
... ... ... College of American Pathologists (CAP) released the new CAP electronic Cancer Checklists (CAP eCC)—the XML ... enhance and advance cancer reporting., , , , ,The latest CAP eCC release contains all ...
... ... , ... 8, 2010 -- After more than 20 years with very little innovation, the world of ... tool for cast removal. , , , , ,With an operating sound level just above ...
Cached Medicine News:Health News:Blood test could improve graft-versus-host disease treatment 2Health News:Blood test could improve graft-versus-host disease treatment 3Health News:How high can a climber go? 2Health News:Texas A&M prof working on new ways to see through the human body 2Health News:New Low Dose CT Protocols for Stone Detection may Hold Key to Reducing Cancer Risk from Radiation 2Health News:New Low Dose CT Protocols for Stone Detection may Hold Key to Reducing Cancer Risk from Radiation 3Health News:College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC) 2Health News:College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC) 3Health News:College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC) 4Health News:New 'Kid-Friendly' Cast Removal Tool Now at Sanford 2
Landolt hypophysectomie instrument, spoon, bayonet-shaped, flexible....
Cushing pituitary scoop, malleable, silver-plated....
... Cougar is an Anterior Spinal Implant system. ... approximating that of cortical bone. The result ... requirements of anterior column support, while optimizing ... sharing design. Incorporates an anatomic design with ...
... The Stackable Cage System provides anterior column ... total vertebrectomies from T1 to L5. The ... Carbon Fiber Polymer cages that are stacked ... needs. The Peek Carbon Fiber Reinforced Polymer ...
Medicine Products: